SENORES PHARMACEUTICALS L (SENORES) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.029x

Based on the latest financial reports, SENORES PHARMACEUTICALS L (SENORES) has a cash flow conversion efficiency ratio of 0.029x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs242.20 Million ≈ $2.62 Million USD) by net assets (Rs8.34 Billion ≈ $90.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SENORES PHARMACEUTICALS L (SENORES) balance sheet quality index to measure how much of total assets are equity-financed.

SENORES PHARMACEUTICALS L - Cash Flow Conversion Efficiency Trend (2022–2025)

This chart illustrates how SENORES PHARMACEUTICALS L's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check SENORES operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

SENORES PHARMACEUTICALS L Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SENORES PHARMACEUTICALS L ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Arvind Fashions Limited NSE:ARVINDFASN	0.103x
Vestum AB (publ) ST:VESTUM	0.014x
Vitesse Energy Inc NYSE:VTS	0.042x
ODDITY Tech Ltd. Class A Ordinary Shares NASDAQ:ODD	-0.023x
Autoneum Holding AG SW:AUTN	0.178x
Southern Cable Group Bhd KLSE:0225	0.036x
India Tourism Development Corporation Limited NSE:ITDC	0.014x
Talkspace Inc NASDAQ:TALK	0.044x

Annual Cash Flow Conversion Efficiency for SENORES PHARMACEUTICALS L (2022–2025)

The table below shows the annual cash flow conversion efficiency of SENORES PHARMACEUTICALS L from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see SENORES stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs94.96 Million ≈ $1.03 Million	Rs-459.20 Million ≈ $-4.97 Million	-4.836x	-4260.01%
2024-03-31	Rs2.32 Billion ≈ $25.06 Million	Rs-257.00 Million ≈ $-2.78 Million	-0.111x	-367.70%
2023-03-31	Rs454.99 Million ≈ $4.92 Million	Rs-10.79 Million ≈ $-116.69K	-0.024x	+91.69%
2022-03-31	Rs365.90 Million ≈ $3.96 Million	Rs-104.47 Million ≈ $-1.13 Million	-0.286x	--

About SENORES PHARMACEUTICALS L

NSE:SENORES India Drug Manufacturers - General

Market Cap

$650.31 Million

Rs60.13 Billion INR

Market Cap Rank

#10743 Global

#541 in India

Share Price

Rs1305.70

Change (1 day)

+1.03%

52-Week Range

Rs647.10 - Rs1480.90

All Time High

Rs1480.90